📘 New JAMA Review: Ovarian Cancer – From Symptoms to Survival 🌸

Approximately 21,000 women are diagnosed with ovarian cancer annually in the U.S.—and 80% present with advanced-stage disease.

The latest JAMA review by Caruso, Weroha, and Cliby (2025) offers a comprehensive update on:

🧬 Evolving genetic insights (BRCA1/2, HRD, Lynch)

🩺 Diagnostic strategies beyond CA-125

💊 State-of-the-art therapies: surgery, chemo, PARP inhibitors, bevacizumab

📉 Declining mortality trends due to prevention and early detection

With clear tables, evidence-based algorithms, and nuanced discussion on fertility-sparing surgery and maintenance therapy, this is a must-read for oncologists, gynecologists, and policy advocates alike.

#JAMA #OvarianCancer #WomensHealth #Oncology #BRCA #PARPinhibitors #GeneticTesting #CancerCare #GynecologicOncology #PrecisionMedicine